RR
Rebecca Redfield
Associate at .406 Ventures
United States
Overview
Rebecca Redfield is a Healthcare Investor at .406 Ventures in the United States, specializing in investing in Series A and Seed stages within sectors such as Consumer Health and Digital Health in the Boston/New England area. With a background in management, she has held roles at Takeda Digital Ventures and Foundation Medicine, showcasing expertise in leadership and investment management.
Work Experience
Associate
2023 - Current
.406 Ventures provides capital and support for early stage technology companies.
Investment Manager
2022 - 2023
Investor
2021 - 2022
Data, Digital, & Technology Analyst
2021 - 2021
Cloud FinOps Analyst
2019 - 2020
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Raised $96,500,000.00 from Evan Jones, Bill Gates, Third Rock Ventures, Kleiner Perkins, Casdin Capital, Deerfield Capital Management, Google Ventures, Roche Venture Fund and Redmile Group.